News & Publications

Mr. Cooper Group in the agreement by its wholly owned subsidiary, Nationstar Mortgage, to purchase the mortgage operations from Flagstar Bank

T-Mobile in its $4.9 billion joint venture with KKR to acquire Metronet

An Ad Hoc Group of Second Lien Noteholders in AMC’s $2.45 billion debt restructuring

Alberto Safra’s resolution to divest his interests in the J. Safra group and pursue his future business through ASA Investments

Broadcom in its $5 billion registered public senior notes offering

Sharecare in its $540 million acquisition by an affiliate of Altaris

EQ in its incremental term loan in connection with a dividend recapitalization

Phoenix Retail in its Section 363 acquisition of substantially all assets of Express

Bank of Hawaii in its public offering of 8.000% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B

Becton Dickinson in its public notes offering to fund in part the acquisition of the Edwards Lifesciences Corporation

ConocoPhillips in its $22.5 billion all-stock acquisition of Marathon Oil

Santander Holdings USA in its fixed-to-floating senior notes offering

Independent Bank Group in its $2 billion all-stock acquisition by SouthState

AIG in its $3.8 billion sale of a 20% ownership stake of Corebridge to Nippon Life

National MI in its $425 million senior notes offering

National MI in its $250 million five-year unsecured revolving credit facility

Lionsgate in its $383 million exchange agreement

Office Properties Income Trust in its private offer to exchange its outstanding unsecured notes for new 9.000% Senior Secured Notes due 2029

Heartland Financial in its $2 billion all-stock acquisition by UMB Financial

Zoetis in the $350 million sale of its medicated feed additive and water soluble products portfolio to Philbro

Apollo Global Management in its $1.85 billion all-cash acquisition of U.S. Silica

BGC Group, Inc. in the investment by a consortium of 10 banks, into FMX

T-Mobile in its $3 billion joint venture with EQT Infrastructure VI to acquire Lumos

Perrigo Company plc in the €275 million sale of its HRA Pharma Rare Diseases business

Previous

Page 14 of 52

Next